These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

821 related items for PubMed ID: 24258574

  • 21. Stereotactic ablative body radiotherapy for lung cancer.
    Franks KN, Jain P, Snee MP.
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
    [Abstract] [Full Text] [Related]

  • 22. Stereotactic body radiation therapy for stage I non-small cell lung cancer.
    Chang JY, Roth JA.
    Thorac Surg Clin; 2007 May; 17(2):251-9. PubMed ID: 17626403
    [Abstract] [Full Text] [Related]

  • 23. [Stereotactic body radiotherapy for malignant nodules in the lung].
    Nestle U, Guckenberger M.
    Zentralbl Chir; 2013 Oct; 138 Suppl 1():S25-31. PubMed ID: 24150852
    [Abstract] [Full Text] [Related]

  • 24. Stereotactic body radiation therapy for lung cancer: achievements and perspectives.
    Hiraoka M, Matsuo Y, Takayama K.
    Jpn J Clin Oncol; 2010 Sep; 40(9):846-54. PubMed ID: 20670962
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS, Schytte T, Jensen HR, Brink C, Hansen O.
    Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
    [Abstract] [Full Text] [Related]

  • 32. Forecasting the impact of stereotactic ablative radiotherapy for early-stage lung cancer on the thoracic surgery workforce.
    Edwards JP, Datta I, Hunt JD, Stefan K, Ball CG, Dixon E, Grondin SC.
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1599-606. PubMed ID: 26796110
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant.
    Bradley JD, El Naqa I, Drzymala RE, Trovo M, Jones G, Denning MD.
    Int J Radiat Oncol Biol Phys; 2010 Jul 15; 77(4):1146-50. PubMed ID: 19800181
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?
    Mahmood S, Bilal H, Faivre-Finn C, Shah R.
    Interact Cardiovasc Thorac Surg; 2013 Nov 15; 17(5):845-53. PubMed ID: 23900381
    [Abstract] [Full Text] [Related]

  • 37. SBRT effective for inoperable early-stage lung cancer.
    Cancer Discov; 2014 Dec 15; 4(12):OF2. PubMed ID: 25477119
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.
    Nguyen NP, Garland L, Welsh J, Hamilton R, Cohen D, Vinh-Hung V.
    Cancer Treat Rev; 2008 Dec 15; 34(8):719-27. PubMed ID: 18657910
    [Abstract] [Full Text] [Related]

  • 40. SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?
    Chen H, Louie AV.
    Curr Treat Options Oncol; 2016 Jun 15; 17(6):27. PubMed ID: 27098533
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.